# Immunogenicity and Safety of DCs in Breast Cancer

> **NCT03450044** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fundación Salud de los Andes** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer Female

## Interventions

- **BIOLOGICAL:** Dendritic cells

## Key facts

- **NCT ID:** NCT03450044
- **Lead sponsor:** Fundación Salud de los Andes
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2018-07
- **Final completion:** 2018-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-02-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03450044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03450044, "Immunogenicity and Safety of DCs in Breast Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03450044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*